S

Spyre Therapeutics

Clinical-stage biotech antibodies for IBD

Senior Director, Intellectual Property Counsel

Intellectual Property (IP)Confirmed live in the last 24 hours
Full-timeRemote in USA

About the Job

Requirements

  • A J.D. from an accredited law school is required.
  • Active admission to at least one U.S. state bar and registration to practice before the U.S. Patent and Trademark Office are required.
  • At least 12 years of relevant biotechnology or pharmaceutical patent law experience are required.
  • Experience at a leading intellectual property law firm and within an in-house biotechnology or pharmaceutical legal department is required.
  • Strong technical understanding of biological and pharmaceutical drug discovery and development, particularly biologics, antibodies, immunology, and inflammation, is required.
  • Extensive hands-on experience drafting and prosecuting U.S. and international patent applications and managing complex global patent portfolios is required.
  • Experience with patent disputes, oppositions, or other post-grant proceedings is required.
  • Demonstrated experience conducting freedom-to-operate, patentability, validity, and infringement analyses is required.
  • Experience supporting intellectual property due diligence and negotiating intellectual property provisions in licensing and collaboration agreements is required.
  • The candidate must be able to oversee outside counsel, manage budgets, and prioritize competing demands.
  • The candidate must be able to explain complex legal and scientific issues clearly and provide actionable advice.
  • The candidate must be able to work independently, exercise sound judgment, and build effective relationships across scientific and business teams.

Responsibilities

  • Develop and execute global intellectual property strategies aligned with the company’s pipeline, research priorities, and corporate objectives.
  • Build and manage patent portfolios covering drug candidates, formulations, manufacturing processes, methods of use, and other innovations.
  • Draft, review, and oversee the preparation and prosecution of U.S. and international patent applications.
  • Evaluate invention disclosures and partner with scientists to identify patentable discoveries and develop appropriate filing strategies.
  • Identify and ensure protection of trade secrets.
  • Conduct and oversee freedom-to-operate, patentability, validity, and infringement analyses; communicate findings and recommend approaches to address identified risks.
  • Support life cycle and exclusivity planning, including patent term extension opportunities and coordination with Regulatory and other relevant functions.
  • Monitor competitor patent activity and emerging intellectual property developments relevant to the company’s programs.
  • Support trademark clearance and protection for product brand names.
  • Advise discovery, translational science, CMC, clinical development, and other internal teams on intellectual property matters.
  • Translate scientific findings and development plans into actionable patent strategies.
  • Review proposed publications, presentations, and other external disclosures to protect intellectual property while supporting scientific communication.
  • Provide guidance on inventorship, ownership, confidentiality, trade secrets, and intellectual property risks.
  • Educate internal stakeholders on intellectual property practices and encourage timely identification and disclosure of inventions.
  • Partner with Business Development and Legal colleagues on intellectual property aspects of licensing, research collaborations, co-development agreements, material transfer agreements, and other strategic transactions.
  • Conduct and support intellectual property due diligence for potential partnerships, licensing opportunities, and other business development activities.
  • Draft, review, and negotiate intellectual property provisions addressing ownership, prosecution, enforcement, and licensing rights.
  • Support intellectual property obligations and governance under existing collaboration and license agreements.
  • Select, direct, and oversee outside patent counsel and other intellectual property service providers globally.
  • Ensure patent preparation and prosecution reflect the company’s scientific priorities, business objectives, and quality standards.
  • Oversee patent dockets, filing deadlines, annuities, and portfolio records in coordination with external providers.
  • Manage intellectual property budgets, forecasts, and outside counsel spending.
  • Recommend portfolio prioritization and resource allocation as programs and business needs evolve.
  • Develop and execute intellectual property strategies that support the pipeline and long-term business objectives.
  • Take increasing responsibility for setting company-wide intellectual property priorities, advising executive leadership, and leading the intellectual property function.

Desired Qualifications

  • In-house experience at an early-stage or rapidly growing biopharmaceutical company.
  • Experience supporting antibody therapeutics, combination therapies, and programs in immunology or inflammatory diseases.
  • Experience with patent disputes, oppositions, or other post-grant proceedings.

About the Company

Spyre Therapeutics

Clinical-stage biotech antibodies for IBD

Spyre Therapeutics develops long-acting antibody therapies for inflammatory bowel disease (IBD), targeting ulcerative colitis and Crohn’s disease with programs such as anti-α4β7 and anti-TL1A. These antibodies are designed to inhibit immune pathways in the gut to reduce inflammation and are built for durable effects, aiming for patient-friendly dosing and potential combo-therapy use. Unlike some peers, Spyre focuses on best-in-class antibodies with durability and a diversified pipeline, shifting away from its past enzyme programs toward immunology-driven treatments for large GI markets. The company aims to discover, develop, and potentially commercialize antibody therapies that address unmet needs in IBD and improve long-term patient outcomes.

Company size
51-200
Company stage
IPO
Headquarters
Waltham, MA
Founded
2023

Recently Posted Jobs

Explore more opportunities at Spyre Therapeutics

See more jobs